J Cianciara

410 total citations
35 papers, 328 citations indexed

About

J Cianciara is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, J Cianciara has authored 35 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 29 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in J Cianciara's work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). J Cianciara is often cited by papers focused on Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). J Cianciara collaborates with scholars based in Poland, United States and Spain. J Cianciara's co-authors include Tomasz Laskus, Marek Radkowski, Hugo E. Vargas, J Slusarczyk, Jorge Rakela, W. J. Brzosko, Andrzej Horban, DF Gray, Graham Farrell and Jenny Heathcote and has published in prestigious journals such as Hepatology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

J Cianciara

31 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Cianciara Poland 10 289 289 50 18 18 35 328
Y. Lazizi France 10 199 0.7× 186 0.6× 45 0.9× 16 0.9× 30 1.7× 13 262
Valeria Tedeschi United States 4 392 1.4× 359 1.2× 41 0.8× 14 0.8× 13 0.7× 5 412
Kurt W. Roth Germany 7 371 1.3× 327 1.1× 39 0.8× 24 1.3× 21 1.2× 8 404
Michèle Martinot France 9 419 1.4× 418 1.4× 57 1.1× 13 0.7× 9 0.5× 15 461
E Ibrányi Hungary 5 366 1.3× 339 1.2× 40 0.8× 14 0.8× 9 0.5× 13 386
Frauke Metzler Germany 6 461 1.6× 474 1.6× 31 0.6× 17 0.9× 21 1.2× 6 510
M Capalbo Italy 7 427 1.5× 439 1.5× 67 1.3× 20 1.1× 20 1.1× 12 493
Josephine Simonetti United States 8 640 2.2× 660 2.3× 23 0.5× 33 1.8× 25 1.4× 10 712
U. Oesen Germany 6 497 1.7× 471 1.6× 27 0.5× 15 0.8× 40 2.2× 7 533
T. Santantonio Italy 8 677 2.3× 656 2.3× 74 1.5× 11 0.6× 22 1.2× 17 709

Countries citing papers authored by J Cianciara

Since Specialization
Citations

This map shows the geographic impact of J Cianciara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cianciara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cianciara more than expected).

Fields of papers citing papers by J Cianciara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Cianciara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cianciara. The network helps show where J Cianciara may publish in the future.

Co-authorship network of co-authors of J Cianciara

This figure shows the co-authorship network connecting the top 25 collaborators of J Cianciara. A scholar is included among the top collaborators of J Cianciara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Cianciara. J Cianciara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cianciara, J, et al.. (2010). 300 PHASE 1B DOSE-ESCALATION STUDY OF SD-101, A NOVEL THERAPEUTIC TLR-9 AGONIST, IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS. Journal of Hepatology. 52. S126–S126. 3 indexed citations
2.
3.
Zeuzem, Stefan, Yves Horsmans, Rafael Esteban, et al.. (2005). Efficacy of 6 months treatment with PEG-interferon alpha-2b plus ribavirin (P/R) in patients infected with hepatitis C with genotype 1 of low viral load (G1LVL). Journal of Hepatology. 42. 229. 5 indexed citations
4.
Gish, Robert G., S. Hadziyannis, J Cianciara, et al.. (2004). 428 Lamivudine-refractory hepatitis B patients can be safely switched directly to entecavir 1 mg daily therapy. Journal of Hepatology. 40. 127–127. 5 indexed citations
5.
Chang, Ting‐Tsung, S. Hadziyannis, J Cianciara, et al.. (2002). Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in subjects with chronic hepatitis B who have failed lamivudine.. Hepatology. 36(4). 21 indexed citations
6.
Kozłowska, Joanna, et al.. (2001). [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].. PubMed. 55(4). 451–8. 8 indexed citations
7.
Juszczyk, Jacek, Beata Bolewska, J Cianciara, et al.. (2000). Combination therapy with interferon alpha-2b and ribavirin in naive patients with chronic hepatitis C. Journal of Hepatology. 32. 199–199. 5 indexed citations
8.
Schiff, Eugene R., J Cianciara, Selim Karayalçın, et al.. (2000). Durable HBeAg and HBsAg seroconversions after lamivudine for chronic hepatitis B (CHB). Journal of Hepatology. 32. 99–99. 24 indexed citations
9.
Radkowski, Marek, et al.. (1998). Hepatitis G virus coinfection in chronic hepatitis B and C patients in Poland. Infection. 26(2). 113–115. 4 indexed citations
10.
11.
Laskus, Tomasz, Jorge Rakela, J Cianciara, et al.. (1997). Comparison of hepatitis B virus core promoter sequences in peripheral blood mononuclear cells and serum from patients with hepatitis B.. Journal of General Virology. 78(3). 649–653. 11 indexed citations
12.
Laskus, Tomasz, et al.. (1993). [Markers of hepatitis A infection in drug addicts].. PubMed. 48(11-13). 261–2. 1 indexed citations
13.
Laskus, Tomasz, et al.. (1992). Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland. Journal of Hepatology. 15(1-2). 114–117. 12 indexed citations
14.
Laskus, Tomasz, et al.. (1992). Prevalence of markers of hepatitis viruses in out-patient alcoholics. Journal of Hepatology. 15(1-2). 174–178. 25 indexed citations
15.
Laskus, Tomasz, et al.. (1991). Acute non-A, non-B hepatitis in a hospital population in Warsaw, Poland: clinical and epidemiological aspects.. PubMed. 86(5). 565–9. 1 indexed citations
16.
Stasiak, Anna, et al.. (1990). [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].. PubMed. 45(16-18). 347–51. 1 indexed citations
17.
Laskus, Tomasz, et al.. (1990). Exacerbation of chronic active hepatitis type B after short-term corticosteroid therapy resulting in fatal liver failure.. PubMed. 85(10). 1414–7. 16 indexed citations
18.
Laskus, Tomasz, et al.. (1990). Liver disease among Polish alcoholics. Contribution of chronic active hepatitis to liver pathology. Liver International. 10(4). 221–228. 4 indexed citations
19.
Cianciara, J, et al.. (1984). [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation].. PubMed. 39(33). 1097–101. 1 indexed citations
20.
Cianciara, J, et al.. (1977). Clinical and Immunological Studies on Healthy Blood Donors Hepatitis B Antibody Carriers. Vox Sanguinis. 33(2). 88–92.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Lazizi Breakdown of academic impact, for papers by Valeria Tedeschi Breakdown of academic impact, for papers by Kurt W. Roth Breakdown of academic impact, for papers by Michèle Martinot Breakdown of academic impact, for papers by E Ibrányi Breakdown of academic impact, for papers by Frauke Metzler Breakdown of academic impact, for papers by M Capalbo Breakdown of academic impact, for papers by Josephine Simonetti Breakdown of academic impact, for papers by U. Oesen Breakdown of academic impact, for papers by T. Santantonio
Rankless by CCL
2026